Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Dana Incorporated enters its October 28 earnings report with options markets at their most defensive reading of the past year, even as short sellers pull back and the borrow market stays comfortably loose.
The clearest tension this week is in options. The put/call ratio hit 2.50 on Tuesday, its highest mark of the past 52 weeks and above the 20-day average of 2.33. At 1.58 standard deviations above that mean, the move is notable without being extreme. Put volume has been running consistently heavy across September and October, suggesting investors have been layering on downside protection rather than making a sharp reactive move. The setup points to hedging ahead of the print, not panic.
Short positioning tells a contrasting story. Bears have been trimming. Short interest dipped roughly 5% over the past month to 3.87% of the free float, around 4.52 million shares. The borrow market is not under any pressure. Availability is extremely loose, at 9,198%, meaning there are roughly 92 shares available to lend for every one already borrowed. Cost to borrow has fallen 26% over the past month and now sits at just 0.44%, near a commodity rate. Taken together, the lending data shows no meaningful squeeze risk and no rush by new bears to build positions.
The Street is cautiously constructive but has been marking targets lower. UBS analyst Joseph Spak cut his target to $36 from $38 earlier today while holding a Buy rating. That follows a string of reductions from multiple firms after the August results, including Wells Fargo trimming to $28 and RBC Capital pulling its target down from $41 to $37 in July before nudging it back to $37 in August. The mean price target across the covering group is $38.67, implying roughly 36% upside to the $28.43 close. Bulls point to $250 million in realised cost savings and management lifting its cumulative target to $325 million through 2026, alongside peer multiple expansion from 4.5x to 5.0x on 2026 EBITDA. Bears counter with guidance for flat sales around $7.5 billion, OEM pricing pressure, and commodity cost exposure. Valuation sits at 7.8x trailing earnings and 4.4x EV/EBITDA, both compressing over the past 30 days. EPS momentum over 30 and 90 days ranks in the 91st to 92nd percentile of the universe, but forward earnings growth ranks in just the 5th percentile, a stark disconnect.
The activist dimension adds a layer worth tracking. Icahn Partners Master Fund filed a Schedule 13D on Dana in January 2025 and amended it in June 2025, the most recent public disclosure showing a prior stake near 9.85%. As of that last filing, the position is still on the 13D register, which signals activist intent. A holder can exit below the 5% reporting threshold without a further filing, so the current stake is as last disclosed and may not reflect today's position. That caveat aside, the presence of an unresolved 13D filing keeps the corporate strategy question open heading into results.
Dana's recent earnings history is short but readable. The August Q2 print produced a 1.5% next-day gain and an 8.2% five-day move. The prior quarter saw a 1.2% one-day decline but recovered to a 2.3% gain over five sessions. Neither reaction was dramatic, which may partly explain why options hedging is heavy in aggregate but the short side has not crowded.
The week of October 28 brings the next read on whether cost savings are landing as promised and whether volume trends in commercial vehicles are holding up. With options at their most defensive in a year and the Icahn 13D unresolved, what the company says about 2027 framework and capital allocation may matter as much as the Q3 number itself.
See the live data behind this article on ORTEX.
Open DAN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
